Revelation Biosciences, Inc. (REVB) vs Virax Biolabs Group Limited (VRAX)

Revelation Biosciences, Inc. and Virax Biolabs Group Limited are both Biotechnology companies. Revelation Biosciences, Inc. and Virax Biolabs Group Limited are of similar size ($3.5M and $3.3M). Across the 9 metrics below, Virax Biolabs Group Limited leads on 6 and Revelation Biosciences, Inc. on 3.

Valuation

Metric REVB VRAX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.33 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.73 0.86 0.74
EV/Sales n/m n/m 10.73
Earnings yield (1,414.94%) (222.08%) (28.84%)
Free cash flow yield (283.36%) 0.00% (23.03%)

Profitability

Metric REVB VRAX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (276.43%) 0.00% (57.72%)
Return on assets (214.63%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric REVB VRAX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 97.72% 68.79% —
Revenue growth, 5-year CAGR — (36.88%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REVB VRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.21 9.97 4.73
Net debt to EBITDA 1.18 1.08 0.96

Dividend

Metric REVB VRAX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric REVB VRAX Biotechnology median
Market cap 3.47m 3.28m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack